LBRX
LBRX
US50180M1080
LB Pharmaceuticals Inc
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
30.404.000 64.830.000
53.1%
Operating Income -30.404.000 -64.830.000
53.1%
Pretax Income -25.204.000 -63.101.000
60.1%
Net Income Common Stockholders -25.205.000 -63.102.000
60.1%
-- --
--
-- --
--
ende